These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19563888)

  • 1. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
    Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.
    Li L; Sun C; Yang F; Yang S; Feng X; Gu J; Han W; Langford PR; Lei L
    Vaccine; 2013 Oct; 31(45):5269-75. PubMed ID: 24051157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.
    Oldfield NJ; Donovan EA; Worrall KE; Wooldridge KG; Langford PR; Rycroft AN; Ala'Aldeen DA
    Vaccine; 2008 Apr; 26(16):1942-54. PubMed ID: 18342410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
    Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of an Actinobacillus pleuropneumoniae outer membrane lipoprotein (OmlA) from serotype 5a.
    Ito H; Uchida I; Sekizaki T; Ooishi E; Kawai T; Okabe T; Taneno A; Terakado N
    Microb Pathog; 1995 Jan; 18(1):29-36. PubMed ID: 7783596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.
    Fu S; Ou J; Zhang M; Xu J; Liu H; Liu J; Yuan F; Chen H; Bei W
    Clin Vaccine Immunol; 2013 Feb; 20(2):134-9. PubMed ID: 23220998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
    Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
    Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of AasP, a maturation protease autotransporter protein of Actinobacillus pleuropneumoniae.
    Ali T; Oldfield NJ; Wooldridge KG; Turner DP; Ala'Aldeen DA
    Infect Immun; 2008 Dec; 76(12):5608-14. PubMed ID: 18852244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J; Nechvatalova K; Krejci J; Kudlacková H; Brazdova I; Kucerova Z; Faldyna M
    Vaccine; 2008 Nov; 26(50):6368-72. PubMed ID: 18824203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.
    Willson PJ; Rossi-Campos A; Potter AA
    Can J Vet Res; 1995 Oct; 59(4):299-305. PubMed ID: 8548692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
    Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
    Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
    Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
    Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
    Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
    Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.